Who Gilead buys from and sells to
Makes HIV drugs (Biktarvy, Descovy, Yeztugo), plus liver-disease, oncology and cell-therapy medicines.
Buys from 0
None recorded
Sells to 4
- Cardinal HealthCAHwholesale distribution in the US29% of gross product sales (FY2025 10-K)
- McKessonMCKwholesale distribution in the US24% of gross product sales (FY2025 10-K)
- CencoraCORwholesale distribution in the US21% of gross product sales (FY2025 10-K)
- Johnson & JohnsonJNJFTC/TAF for Symtuza and Odefsey, paid as revenue share
Where the chain could break
- HIV drugs were $20.8bn of 2025 product sales, most of the business
- Three wholesalers take ~74% of gross product sales
Competes with
Mapped by hand from filings and company reporting, as of October 2026. It shows the relationships that matter most, not every contract: most are never disclosed, and agreements change.